Dr. Symer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd.
Unit 903
Houston, TX 77030Phone+1 713-745-5233
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 2002
Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1995- Johns Hopkins University School of MedicineClass of 1993
Certifications & Licensure
OH State Medical License 2010 - 2026
MD State Medical License 1996 - 2025
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets.Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, Minghao Dang, Amishi Vora
Cell Reports. Medicine. 2025-02-18 - Targeting Caseinolytic Mitochondrial Matrix Peptidase, a Novel Contributor to High-risk Behavior, in Multiple Myeloma.Li Qin, Luz Yurany Moreno Rueda, Upasana Ray, Iqbal Mahmud, Lin Tan
Blood. 2025-02-06 - 5 citationsTargeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma.Sonia M Setayesh, Libere J Ndacayisaba, Kate E Rappard, Valerie Hennes, Luz Yurany Moreno Rueda
NPJ Precision Oncology. 2023-09-18
Press Mentions
MD Anderson Research Highlights for February 22, 2023February 22nd, 2023
DNA Looping Damage Tied to HPV Cancer, Researcher DiscoversApril 16th, 2014
HPV Can Damage Genes, Chromosomes Directly by Inserting Own DNA into Human DNANovember 7th, 2013- Join now to see all
Grant Support
- Genomic, Transcriptional And Epigenetic Variation Due To RetrotranspositionDivision Of Basic Sciences - Nci2009
- Characterization Of Candidate Histone MethyltransferasesDivision Of Basic Sciences - Nci2009
- Genomic, Transcriptional And Epigenetic Variation Due To RetrotranspositionNational Cancer Institute2007–2008
- Characterization Of Candidate Histone MethyltransferasesNational Cancer Institute2007–2008
- Epigenetic Control Of Mammalian RetrotransposonsDivision Of Basic Sciences - Nci2005–2006
- Characterization Of Candidate Histone MethyltransferasesDivision Of Basic Sciences - Nci2005–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
